Failed HIV Therapy May Combat COVID-19-induced PF

Failed HIV Therapy May Combat COVID-19-induced PF

295294

Failed HIV Therapy May Combat COVID-19-induced PF

An experimental therapy that proved ineffective in treating HIV infections now has shown promising potential at preventing or limiting pulmonary fibrosis (PF) caused by SARS-CoV-2, the virus that causes COVID-19. That finding, from a mouse model of induced PF, was detailed in the study  “Targeting RUNX1 prevents pulmonary fibrosis and reduces expression of SARS-CoV-2 host mediators,” published in The American Journal of Pathology. Despite the recent development of medications to slow fibrosis, or tissue scarring, that…

You must be logged in to read/download the full post.